I think the main issue is retail vs wholesale. (BGI’s $600 probably means volume pricing.) Also, I think NHGRI publishes averages over deployed machines, including old ones, which overestimates the cost of buying a new machine to create new capacity.
Dante is a retail commercial product of $700 for a whole genome. Dante and Veritas had previously had sales of $200 and $300 (which was probably measuring the demand curve and doesn’t say much about cost). Two days after writing this comment, Veritas cut its price in half to $600, below Dante.
I think the main issue is retail vs wholesale. (BGI’s $600 probably means volume pricing.) Also, I think NHGRI publishes averages over deployed machines, including old ones, which overestimates the cost of buying a new machine to create new capacity.
Dante is a retail commercial product of $700 for a whole genome. Dante and Veritas had previously had sales of $200 and $300 (which was probably measuring the demand curve and doesn’t say much about cost). Two days after writing this comment, Veritas cut its price in half to $600, below Dante.
I did not know how much work is going on.
Nice post! The plot from NHGRI looks strangely off in my browser. The plateau at the bottom right should be just above $1000 (but looks as if it is closer to $100). The graph in the actual NHGRI page ( https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-cost ) is correct, and so is Wikipedia.